Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
Autoimmunity Reviews|March 16, 2021
The role of innate immunity in myasthenia gravisRui Zhao, Sushan Luo, Chongbo ZhaoAutoimmunity Reviews|July 20, 2019
HLA in myasthenia gravis: From superficial correlation to underlying mechanismHuahua Zhong, Chongbo Zhao, Sushan LuoAutoimmunity Reviews|September 5, 2021
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseasesManqiqige Su, Chongbo Zhao, Sushan LuoOrphanet Journal of Rare Diseases|February 17, 2022
Risk factors for pregnancy-related clinical outcome in myasthenia gravis: a systemic review and meta-analysisManqiqige Su, Xiaoqing Liu, Liang Wang, et al.Frontiers in Neurology|November 12, 2024
Initiation response, maximized therapeutic efficacy, and post-treatment effects of biological targeted therapies in myasthenia gravis: a systematic review and network meta-analysisHuahua Zhong, Zhijun Li, Xicheng Li, et al.Frontiers in Neurology|December 20, 2021
Efficacy and Safety of Immunotherapies in Refractory Myasthenia Gravis: A Systematic Review and Meta-AnalysisXuelin Feng, Zubiao Song, Mengli Wu, et al.Journal of Neuroimmunology|September 22, 2020
Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patientsHuahua Zhong, Jun Lu, Sisi Jing, et al.Journal of Neuroimmunology|May 18, 2019
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravisSisi Jing, Jun Lu, Jie Song, et al.Journal of Neuroimmunology|February 25, 2025
Response of refractory residual ocular symptoms to efgartigimod in generalized myasthenia gravis: A real-world case seriesDingxian He, Yufan Zhou, Yexin Zhang, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxomaChao Quan, Jingzi ZhangBao, Sushan Luo, et al.Pageof 11